The purpose of this study is to evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving.
Evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving as determined by self-report and cocaine-positive urine samples.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
43
20mg q.d. to 70mg b.i.d
University of Minnesota
Minneapolis, Minnesota, United States
maximum total lisdexamfetamine dose achieved during the study period defined as the highest amount of medication per day maintained for a seven day period
Time frame: Study weeks 3-6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.